Cargando…

Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries

Neonatal hyperbilirubinaemia requiring phototherapy treatment is a common problem impacting the length of hospital stay and rates of hospital readmission. Previous guidelines included guidance for initiating phototherapy treatment but not for discontinuing phototherapy treatment during initial newbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Germana, Sarah, Shaikh, Sophie Kay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335425/
https://www.ncbi.nlm.nih.gov/pubmed/37429640
http://dx.doi.org/10.1136/bmjoq-2022-002141
_version_ 1785070996974206976
author Germana, Sarah
Shaikh, Sophie Kay
author_facet Germana, Sarah
Shaikh, Sophie Kay
author_sort Germana, Sarah
collection PubMed
description Neonatal hyperbilirubinaemia requiring phototherapy treatment is a common problem impacting the length of hospital stay and rates of hospital readmission. Previous guidelines included guidance for initiating phototherapy treatment but not for discontinuing phototherapy treatment during initial newborn admission. In response to dissatisfaction from trainees, staff and families regarding the variable approach to discontinuing phototherapy among attending nursery providers, we used quality improvement methodologies to increase utilisation of a rebound hyperbilirubinaemia calculator as a more consistent method for guiding the timing of phototherapy discontinuation. The aim was to increase utilisation of the rebound hyperbilirubinaemia calculator for newborns treated with phototherapy in two newborn nurseries to >90% within 2 years. Sequential interventions focused on increasing provider awareness of the rebound hyperbilirubinaemia calculator and making the calculator simple to access and use. At the university medical centre nursery, the use of the calculator increased from 8.7% to 100%, exceeding the project goal. In the community hospital nursery, there was a statistically significant increase in the rate of utilisation from 3.7% to 79.4%, but this fell slightly below the goal of >90%. Electronic Health Record integration, along with education and addition of prompts to providers, increased utilisation of a rebound hyperbilirubinaemia calculator as a consistent approach for guiding decisions about discontinuing phototherapy treatment in newborns.
format Online
Article
Text
id pubmed-10335425
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103354252023-07-12 Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries Germana, Sarah Shaikh, Sophie Kay BMJ Open Qual Quality Improvement Report Neonatal hyperbilirubinaemia requiring phototherapy treatment is a common problem impacting the length of hospital stay and rates of hospital readmission. Previous guidelines included guidance for initiating phototherapy treatment but not for discontinuing phototherapy treatment during initial newborn admission. In response to dissatisfaction from trainees, staff and families regarding the variable approach to discontinuing phototherapy among attending nursery providers, we used quality improvement methodologies to increase utilisation of a rebound hyperbilirubinaemia calculator as a more consistent method for guiding the timing of phototherapy discontinuation. The aim was to increase utilisation of the rebound hyperbilirubinaemia calculator for newborns treated with phototherapy in two newborn nurseries to >90% within 2 years. Sequential interventions focused on increasing provider awareness of the rebound hyperbilirubinaemia calculator and making the calculator simple to access and use. At the university medical centre nursery, the use of the calculator increased from 8.7% to 100%, exceeding the project goal. In the community hospital nursery, there was a statistically significant increase in the rate of utilisation from 3.7% to 79.4%, but this fell slightly below the goal of >90%. Electronic Health Record integration, along with education and addition of prompts to providers, increased utilisation of a rebound hyperbilirubinaemia calculator as a consistent approach for guiding decisions about discontinuing phototherapy treatment in newborns. BMJ Publishing Group 2023-07-10 /pmc/articles/PMC10335425/ /pubmed/37429640 http://dx.doi.org/10.1136/bmjoq-2022-002141 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Germana, Sarah
Shaikh, Sophie Kay
Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title_full Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title_fullStr Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title_full_unstemmed Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title_short Increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
title_sort increasing utilisation of a rebound hyperbilirubinaemia calculator in two newborn nurseries
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335425/
https://www.ncbi.nlm.nih.gov/pubmed/37429640
http://dx.doi.org/10.1136/bmjoq-2022-002141
work_keys_str_mv AT germanasarah increasingutilisationofareboundhyperbilirubinaemiacalculatorintwonewbornnurseries
AT shaikhsophiekay increasingutilisationofareboundhyperbilirubinaemiacalculatorintwonewbornnurseries